JP2015502340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502340A5 JP2015502340A5 JP2014539044A JP2014539044A JP2015502340A5 JP 2015502340 A5 JP2015502340 A5 JP 2015502340A5 JP 2014539044 A JP2014539044 A JP 2014539044A JP 2014539044 A JP2014539044 A JP 2014539044A JP 2015502340 A5 JP2015502340 A5 JP 2015502340A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- variable region
- chain variable
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552337P | 2011-10-27 | 2011-10-27 | |
| US61/552,337 | 2011-10-27 | ||
| PCT/US2012/062124 WO2013063395A1 (en) | 2011-10-27 | 2012-10-26 | Humanized antibodies to inkt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502340A JP2015502340A (ja) | 2015-01-22 |
| JP2015502340A5 true JP2015502340A5 (enExample) | 2015-12-17 |
Family
ID=48168549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539044A Pending JP2015502340A (ja) | 2011-10-27 | 2012-10-26 | ｉＮＫＴに対するヒト化抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9932402B2 (enExample) |
| EP (1) | EP2755688A4 (enExample) |
| JP (1) | JP2015502340A (enExample) |
| KR (1) | KR20140093964A (enExample) |
| CN (1) | CN103945867B (enExample) |
| AU (1) | AU2012328588C1 (enExample) |
| BR (1) | BR112014009962A2 (enExample) |
| CA (1) | CA2853719A1 (enExample) |
| HK (2) | HK1199405A1 (enExample) |
| IL (1) | IL232017A0 (enExample) |
| RU (1) | RU2014120694A (enExample) |
| SG (1) | SG11201401319XA (enExample) |
| WO (1) | WO2013063395A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014159764A1 (en) * | 2013-03-14 | 2014-10-02 | Amgen Inc. | Chrdl-1 antigen binding proteins and methods of treatment |
| WO2015069697A2 (en) * | 2013-11-05 | 2015-05-14 | Nkt Therapeutics Inc. | Combination therapy |
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| WO2015121393A1 (en) * | 2014-02-14 | 2015-08-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| TWI734975B (zh) * | 2014-06-27 | 2021-08-01 | 美商Ｃ２Ｎ醫療診斷有限責任公司 | 人類化抗-tau抗體 |
| EP3190415B1 (en) * | 2014-07-25 | 2019-05-01 | Riken | Memory invariant nkt cell marker |
| US20160022777A1 (en) * | 2014-07-28 | 2016-01-28 | Nkt Therapeutics Inc. | Combination therapy with il-12 |
| US11933786B2 (en) | 2015-03-30 | 2024-03-19 | Stcube, Inc. | Antibodies specific to glycosylated PD-L1 and methods of use thereof |
| CN109152798B (zh) * | 2015-12-02 | 2022-10-21 | 斯特库比股份有限公司 | 特异于糖基化的pd-1的抗体及其使用方法 |
| EP3436475A1 (en) | 2016-03-29 | 2019-02-06 | STCube & Co., Inc. | Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins |
| AU2017246794B2 (en) | 2016-04-04 | 2024-07-04 | Genzyme Corporation | Anti-complement factor Bb antibodies and uses thereof |
| US11746152B2 (en) | 2016-07-20 | 2023-09-05 | Stcube, Inc. | Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1 |
| SI4339615T1 (sl) * | 2016-09-16 | 2026-01-30 | Shanghai Henlius Biotech, Inc. | Protitelesa anti-pd-1 za uporabo pri zdravljenju raka |
| WO2020156335A1 (zh) * | 2019-01-29 | 2020-08-06 | 上海交通大学 | 一种嵌合抗原受体及其应用 |
| TWI900560B (zh) | 2020-04-20 | 2025-10-11 | 美商健臻公司 | 人類化抗補體因子bb抗體及其用途 |
| CN115666586A (zh) * | 2020-04-23 | 2023-01-31 | 加州大学评议会 | 通过激活iNKT细胞清除衰老细胞 |
| EP4301374A4 (en) | 2021-03-01 | 2025-09-10 | Deciduous Therapeutics Inc | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119248B1 (en) | 1994-04-12 | 2006-10-10 | Miltenyi Biotec Gmbh | Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| WO1997016203A1 (en) | 1995-11-01 | 1997-05-09 | Genetics Institute, Inc. | Methods for administration of il-12 |
| US6162609A (en) | 1997-12-31 | 2000-12-19 | The Brigham And Women's Hospital, Inc. | Diagnostic and therapeutic methods based upon Vα24JαQT cells |
| EP1297017B1 (en) * | 2000-06-19 | 2012-06-13 | Beth Israel Deaconess Medical Center | Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| CA2454048C (en) * | 2001-07-17 | 2011-05-03 | Research Development Foundation | Therapeutic agents comprising pro-apoptotic proteins |
| ATE549064T1 (de) | 2002-06-14 | 2012-03-15 | Us Gov Health & Human Serv | Verfahren zur behandlung und prävention von kolitis, die il-13 und nk-t zellen betrifft |
| US9809654B2 (en) * | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
| AU2005280163B2 (en) | 2004-08-27 | 2011-11-24 | Albert Einstein College Of Medicine, Inc. | Ceramide derivatives as modulators of immunity and autoimmunity |
| ATE539757T1 (de) * | 2004-11-02 | 2012-01-15 | Univ Leland Stanford Junior | Verfahren zur hemmung von nkt-zellen |
| PE20071101A1 (es) | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| WO2008140487A2 (en) | 2006-11-14 | 2008-11-20 | Elusys Therapeutics, Inc. | Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use |
| WO2008100912A1 (en) * | 2007-02-12 | 2008-08-21 | The General Hospital Corporation | Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| US8012484B2 (en) * | 2007-04-12 | 2011-09-06 | University Of Virginia Patent Foundation | Method of treating ischemia reperfusion injury by inhibiting NKT cell activity |
| WO2009015279A2 (en) * | 2007-07-24 | 2009-01-29 | National Jewish Medical And Research Center | Agents and methods for inhibition of airway hyperresponsiveness |
| WO2009026412A1 (en) | 2007-08-21 | 2009-02-26 | Children's Medical Center Corporation | Treatment of airway hyperreactivity |
| EP2586797A3 (en) * | 2007-11-27 | 2013-07-24 | Medtronic, Inc. | Humanized anti-amyloid beta antibodies |
| GB0902916D0 (en) * | 2009-02-20 | 2009-04-08 | Fusion Antibodies Ltd | Antibody therapy |
| US8835613B2 (en) | 2010-03-12 | 2014-09-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | β-mannosylceramide and stimulation of NKT cell anti-tumor immunity |
| EP2575824A4 (en) | 2010-05-24 | 2014-02-19 | Childrens Medical Center | METHOD FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES |
| EP2785683B1 (en) | 2011-11-30 | 2020-02-05 | Ludwig Institute for Cancer Research Ltd. | Inkt cell modulators and methods of using the same |
| WO2015069697A2 (en) | 2013-11-05 | 2015-05-14 | Nkt Therapeutics Inc. | Combination therapy |
| US20160022777A1 (en) | 2014-07-28 | 2016-01-28 | Nkt Therapeutics Inc. | Combination therapy with il-12 |
-
2012
- 2012-10-26 EP EP12843689.6A patent/EP2755688A4/en not_active Withdrawn
- 2012-10-26 AU AU2012328588A patent/AU2012328588C1/en not_active Ceased
- 2012-10-26 BR BR112014009962A patent/BR112014009962A2/pt not_active IP Right Cessation
- 2012-10-26 CN CN201280053174.3A patent/CN103945867B/zh not_active Expired - Fee Related
- 2012-10-26 CA CA2853719A patent/CA2853719A1/en not_active Abandoned
- 2012-10-26 KR KR1020147014125A patent/KR20140093964A/ko not_active Abandoned
- 2012-10-26 US US13/661,386 patent/US9932402B2/en not_active Expired - Fee Related
- 2012-10-26 RU RU2014120694/10A patent/RU2014120694A/ru not_active Application Discontinuation
- 2012-10-26 WO PCT/US2012/062124 patent/WO2013063395A1/en not_active Ceased
- 2012-10-26 HK HK14113013.0A patent/HK1199405A1/xx unknown
- 2012-10-26 SG SG11201401319XA patent/SG11201401319XA/en unknown
- 2012-10-26 JP JP2014539044A patent/JP2015502340A/ja active Pending
- 2012-10-26 HK HK15100381.0A patent/HK1199837A1/xx unknown
-
2014
- 2014-04-08 IL IL232017A patent/IL232017A0/en unknown